← Back to Search

Behavioural Intervention

Telemedicine-Geriatric Care for Cancer

N/A

Recruiting

Led By William Dale

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age: >=65 years at the time of enrollment

Diagnosis of stage I-IV cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 and 6-months after treatment initiation

Awards & highlights

Study Summary

This trial studies if geriatric assessment-driven interventions using telemedicine can identify areas of vulnerability in older adults with cancer and improve care in underserved communities.

Who is the study for?

This trial is for adults aged 65 or older with stage I-IV cancer, about to start new therapy (chemotherapy, immunotherapy, targeted therapy). They must be able to read English, Spanish, or Chinese and have their physician's approval. Those who may not follow study procedures are excluded.Check my eligibility

What is being tested?

The GAIN-S Trial tests if telemedicine can improve care for older adults with cancer in underserved areas by using geriatric assessments to identify vulnerabilities and guide supportive interventions compared to standard care.See study design

What are the potential side effects?

Since the trial focuses on assessment and support through telemedicine rather than direct medical treatments like drugs or surgery, it does not introduce typical medication side effects. However, there might be indirect effects related to changes in patient care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

My cancer is between stage I and IV.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and at the end of study (36 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and at the end of study (36 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at the end of study (36 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Direct inpatient cost

Number of documented conversations.

Rate of advance directive (AD) completion

Secondary outcome measures

Association of Community Cancer Centers (ACCC) Geriatric Oncology Gap Assessment Tool

Decrease in treatment toxicity

Patient preferences and goals

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ARM I (GAIN-S)Experimental Treatment6 Interventions

Patients complete the CARG-GA at baseline and 3 months and receive GA-based interventions using telemedicine over 6 months.

Group II: ARM II (SOC)Active Control4 Interventions

Receive SOC over the first 3 months, then switch to receive GA-based interventions using telemedicine for the following 3 months. Patients complete the CARG-GA at baseline and 3 months and receive SOC over 6 months.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor

567 Previous Clinical Trials

1,922,444 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,225 Total Patients Enrolled

1 Trials studying Blood Cancers

70 Patients Enrolled for Blood Cancers

William DalePrincipal InvestigatorCity of Hope Medical Center

3 Previous Clinical Trials

467 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively enrolling participants?

"Affirmative. According to the clinicaltrials.gov platform, this experiment has been open for recruitment since July 24th 2023 and was recently revised at September 19th 2023. The trial is seeking 216 participants from 3 cities."

Answered by AI

What is the enrollment rate of this experiment?

"Yes, the available data on clinicaltrials.gov suggest that this trial is still open to enrolling participants. It was initially posted on July 24th 2023 and has been updated as recently as September 19th 2023. The study requires 216 volunteers from 3 different sites."

Answered by AI

What is the desired outcome of this research endeavor?

"This clinical trial's primary outcome, which will be evaluated at the start of treatment and three months following commencement of care, is the total number of conversations that occur between patient and doctor. Secondary goals include determining how many patients experienced grade 3-5 toxicity or needed to change their dose, delay it, or discontinue use altogether; assessing patient satisfaction by using a Was It Worth It (WIWI) questionnaire; and gauging participants' preferences and objectives via the Health Outcomes Questionnaire Now vs Later Tool as well as an attitude scale. Statistical analysis such as chi-square tests for comparing proportion among different cohorts, t-tests for measuring"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial

2023. "Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06022965.